Feasibility of DNA Methylation Age as a Biomarker of Symptoms and Resilience among Cancer Survivors with Multiple Chronic Conditions

Feasibility of DNA Methylation Age as a Biomarker of Symptoms and Resilience among Cancer Survivors with Multiple Chronic Conditions

This study aims to examine the feasibility of DNA methylation age as a biomarker for symptoms and resilience in cancer survivors with multiple chronic conditions (MCCs). We included ten participants from our parent study, an ongoing randomized control trial study. Participants’ symptoms and resilien...

Full description

Bibliographic Details
Main Authors: Nada Lukkahatai, Jongmin Park, Hejingzi Monica Jia, Daniel Martin, Junxin Li, Jennifer Yeong-Shin Sheng, Jessica Gill, Leorey N. Saligan, Vered Stearns, Michael Carducci
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Biomedicines
Subjects:
DNA methylation age
biomarkers
symptom
resilience
cancer survivor
Online Access:https://www.mdpi.com/2227-9059/11/11/3076

Similar Items

Similar Items